Menu

17/12/2020

A study carried out by the UCA shows that treatment with PRP delays arthroplasty

• Twittear

A study carried out by Dr. Mikel Sánchez, Dr. Diego Delgado, Dr. Jorge Guadilla, Pello Sánchez, Cristina Jorquera and Dr. Maider Beitia, all of them specialists and researchers of the Arthroscopic Surgery Unit of Dr. Mikel Sánchez (UCA, according to the Spanish acronym), shows that treatment with Platelet-Rich Plasma (PRP) can delay or even avoid total knee arthroplasty or prosthesis placement in patients with knee osteoarthritis.

Both the delay time and the percentage of patients who did not have to undergo a total knee replacement were analysed. This study was conducted between 2014 and 2019 with 1084 patients and it evaluated variables such as the severity of the pathology, the time when the surgery was performed, the age of the patients, the number of PRP cycles and the route of administration.

The results concluded that 74.1% of patients in the retrospective study (patients with knee osteoarthritis who had knee replacements between 2014 and 2019 and received prior infiltrations) achieved a delay in surgery of more than 1.5 years, with a delay average of 5.3 years. Furthermore, 85.7% of the patients in the survival study (patients with knee osteoarthritis who received PRP treatment during 2014 and were followed-up until 2019) did not undergo such surgery during the five years the follow-up lasted.

Factors such as the degree of severity, the age, PRP cycles and route of administration had an influence on the efficacy of PRP. These data suggest that the application of this treatment can delay the time of performing a knee arthroplasty by up to 10 years. However, more studies are still required to further advance the understanding of this technique and optimize clinical outcomes.

Click here for more information